Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Reul, Johannes M. H. M.
and
Holsboer, Florian
2002.
On the role of corticotropin-releasing hormone receptors in anxiety and depression.
Dialogues in Clinical Neuroscience,
Vol. 4,
Issue. 1,
p.
31.
Sporn, Jonathan
and
Charney, Dennis
2002.
Monoamine and neuropeptide-related function: prospects for novel therapeutics of depression.
Expert Review of Neurotherapeutics,
Vol. 2,
Issue. 2,
p.
217.
Kumar, J.S. Dileep
Majo, Vattoly J.
Prabhakaran, Jaya
Simpson, Norman R.
Van Heertum, Ronald L.
and
Mann, J. John
2003.
Synthesis of [N‐methyl‐11C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐N, N‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine: A potential PET ligand for in vivo imaging of CRF1 receptors.
Journal of Labelled Compounds and Radiopharmaceuticals,
Vol. 46,
Issue. 11,
p.
1055.
Simmen, Urs
Bobirnac, Ionel
Ullmer, Christoph
Lübbert, Hermann
Berger Büter, Karin
Schaffner, Willi
and
Schoeffter, Philippe
2003.
Antagonist effect of pseudohypericin at CRF1 receptors.
European Journal of Pharmacology,
Vol. 458,
Issue. 3,
p.
251.
Kumar, J. S. Dileep
Majo, Vattoly J.
Simpson, Norman R.
Prabhakaran, Jaya
Van Heertum, Ronald L.
and
Mann, J. John
2004.
Synthesis of [O‐methyl‐11C]‐4‐(1,3‐dimethoxy‐2‐propylamino)‐2,7‐dimethyl‐8‐(2,4‐dichlorophenyl)[1,5‐a]pyrazolo‐1,3,5‐triazine ([11C]DMP696): a potential PET ligand for CRF1 receptors.
Journal of Labelled Compounds and Radiopharmaceuticals,
Vol. 47,
Issue. 13,
p.
971.
Saavedra, Juan M.
and
Pavel, Jaroslav
2005.
Angiotensin II AT1 receptor antagonists inhibit the angiotensin‐CRF‐AVP axis and are potentially useful for the treatment of stress‐related and mood disorders.
Drug Development Research,
Vol. 65,
Issue. 4,
p.
237.
Huezo-Diaz, Patricia
Tandon, Kopal
and
Aitchison, Katherine J.
2005.
The genetics of depression and related traits.
Current Psychiatry Reports,
Vol. 7,
Issue. 2,
p.
117.
Pollandt, Sebastian
Liu, Jie
Orozco‐Cabal, Luis
Grigoriadis, Dimitri E.
Vale, Wylie W.
Gallagher, Joel P.
and
Shinnick‐Gallagher, Patricia
2006.
Cocaine withdrawal enhances long‐term potentiation induced by corticotropin‐releasing factor at central amygdala glutamatergic synapses via CRF1, NMDA receptors and PKA.
European Journal of Neuroscience,
Vol. 24,
Issue. 6,
p.
1733.
Kumar, J.S. Dileep
Majo, Vattoly J.
Sullivan, Gregory M.
Prabhakaran, Jaya
Simpson, Norman R.
Van Heertum, Ronald L.
Mann, J. John
and
Parsey, Ramin V.
2006.
Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.
Bioorganic & Medicinal Chemistry,
Vol. 14,
Issue. 12,
p.
4029.
Woelk, H.
Arnoldt, K.H.
Kieser, M.
and
Hoerr, R.
2007.
Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood: A randomized, double-blind, placebo-controlled trial.
Journal of Psychiatric Research,
Vol. 41,
Issue. 6,
p.
472.
Marcil, William
and
Petty, Fred
2007.
xPharm: The Comprehensive Pharmacology Reference.
p.
1.
Petty, Fred
2007.
xPharm: The Comprehensive Pharmacology Reference.
p.
1.
Petersén, Åsa
Wörtwein, Gitta
Gruber, Susanne H.M.
and
Mathé, Aleksander A.
2008.
Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model.
Neuroscience Letters,
Vol. 436,
Issue. 3,
p.
305.
Petersén, Åsa
Wörtwein, Gitta
Gruber, Susanne H.M.
El-Khoury, Aram
and
Mathé, Aleksander A.
2009.
Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model.
Neuroscience Letters,
Vol. 451,
Issue. 2,
p.
148.
Bhattacharya, Supriyo
Subramanian, Govindan
Hall, Spencer
Lin, Jianping
Laoui, Abdelazize
and
Vaidehi, Nagarajan
2010.
Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.
Journal of Computer-Aided Molecular Design,
Vol. 24,
Issue. 8,
p.
659.
Levant, B.
2014.
Reference Module in Biomedical Sciences.
Otsuka, Tomomi
Nishii, Ayu
Amemiya, Seiichiro
Kubota, Natsuko
Nishijima, Takeshi
and
Kita, Ichiro
2016.
Effects of acute treadmill running at different intensities on activities of serotonin and corticotropin-releasing factor neurons, and anxiety- and depressive-like behaviors in rats.
Behavioural Brain Research,
Vol. 298,
Issue. ,
p.
44.
Ma, Li
Demin, Konstantin A.
Kolesnikova, Tatyana O.
Kharsko, Sergey L.
Zhu, Xiaokang
Yuan, Xiaodong
Song, Cai
Meshalkina, Darya A.
Leonard, Brian E.
Tian, Li
and
Kalueff, Allan V.
2017.
Animal inflammation-based models of depression and their application to drug discovery.
Expert Opinion on Drug Discovery,
Vol. 12,
Issue. 10,
p.
995.
Sartori, Simone B.
and
Singewald, Nicolas
2019.
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders.
Pharmacology & Therapeutics,
Vol. 204,
Issue. ,
p.
107402.
Pliota, Pinelopi
Böhm, Vincent
Grössl, Florian
Griessner, Johannes
Valenti, Ornella
Kraitsy, Klaus
Kaczanowska, Joanna
Pasieka, Manuel
Lendl, Thomas
Deussing, Jan M.
and
Haubensak, Wulf
2020.
Stress peptides sensitize fear circuitry to promote passive coping.
Molecular Psychiatry,
Vol. 25,
Issue. 2,
p.
428.